Lakeland Industries, Inc. (NASDAQ:LAKE - Free Report) - Stock analysts at Roth Capital dropped their Q1 2026 earnings estimates for Lakeland Industries in a note issued to investors on Thursday, April 10th. Roth Capital analyst G. Sweeney now expects that the medical instruments supplier will post earnings of $0.27 per share for the quarter, down from their prior forecast of $0.28. The consensus estimate for Lakeland Industries' current full-year earnings is $0.48 per share. Roth Capital also issued estimates for Lakeland Industries' Q4 2026 earnings at $0.36 EPS and FY2027 earnings at $1.69 EPS.
Several other research firms also recently commented on LAKE. Lake Street Capital initiated coverage on shares of Lakeland Industries in a report on Tuesday, March 11th. They issued a "buy" rating and a $30.00 price objective for the company. DA Davidson reduced their price target on Lakeland Industries from $28.00 to $23.00 and set a "buy" rating for the company in a research report on Tuesday. One analyst has rated the stock with a sell rating and four have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $27.00.
Get Our Latest Analysis on Lakeland Industries
Lakeland Industries Stock Performance
NASDAQ LAKE traded down $0.28 during trading on Monday, hitting $15.58. 92,438 shares of the company's stock traded hands, compared to its average volume of 61,117. The stock has a market capitalization of $147.99 million, a price-to-earnings ratio of -173.11 and a beta of 0.86. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.77 and a current ratio of 4.23. The business has a 50 day moving average of $20.28 and a 200-day moving average of $21.69. Lakeland Industries has a 12-month low of $15.25 and a 12-month high of $27.28.
Lakeland Industries (NASDAQ:LAKE - Get Free Report) last released its earnings results on Wednesday, April 9th. The medical instruments supplier reported ($0.54) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.43 by ($0.97). The firm had revenue of $46.60 million during the quarter, compared to analysts' expectations of $47.10 million. Lakeland Industries had a positive return on equity of 1.66% and a negative net margin of 0.42%. During the same period in the prior year, the business earned $0.72 earnings per share.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the company. IFP Advisors Inc bought a new stake in Lakeland Industries during the fourth quarter worth about $36,000. Russell Investments Group Ltd. bought a new stake in Lakeland Industries in the 4th quarter worth approximately $160,000. Bank of America Corp DE boosted its stake in Lakeland Industries by 114.1% in the fourth quarter. Bank of America Corp DE now owns 7,657 shares of the medical instruments supplier's stock worth $196,000 after buying an additional 4,081 shares in the last quarter. Metis Global Partners LLC bought a new position in Lakeland Industries during the fourth quarter valued at approximately $207,000. Finally, Barclays PLC purchased a new position in shares of Lakeland Industries during the third quarter worth approximately $306,000. Institutional investors own 71.69% of the company's stock.
Insider Buying and Selling
In related news, insider Laurel A. Yartz bought 2,272 shares of the company's stock in a transaction on Wednesday, January 22nd. The stock was acquired at an average cost of $22.00 per share, for a total transaction of $49,984.00. Following the completion of the transaction, the insider now directly owns 9,772 shares in the company, valued at $214,984. This trade represents a 30.29 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Nikki Hamblin purchased 1,590 shares of the firm's stock in a transaction dated Wednesday, January 22nd. The stock was bought at an average cost of $22.00 per share, for a total transaction of $34,980.00. Following the acquisition, the director now directly owns 17,452 shares in the company, valued at approximately $383,944. The trade was a 10.02 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 7,998 shares of company stock worth $177,186. Corporate insiders own 4.20% of the company's stock.
Lakeland Industries Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, February 24th. Stockholders of record on Monday, February 17th were issued a $0.03 dividend. The ex-dividend date was Friday, February 14th. This represents a $0.12 annualized dividend and a dividend yield of 0.77%. Lakeland Industries's payout ratio is currently -5.04%.
Lakeland Industries Company Profile
(
Get Free Report)
Lakeland Industries, Inc manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks.
Recommended Stories

Before you consider Lakeland Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lakeland Industries wasn't on the list.
While Lakeland Industries currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.